Elevated expression of integrin αIIb βIIIa in drug-naive, first-episode schizophrenic patients

Background: Patients with schizophrenia have an increased risk over the general public of developing cardiovascular illness. It is unknown if there are functional changes in platelet surface receptors in schizophrenia. We therefore analyzed the surface expression of glycoprotein (GP)Ib, the integrin receptor alpha(IIB)beta(IIIa), CD62 (P-selectin), and CD63, and investigated platelet function in schizophrenic patients compared with healthy volunteers. Methods: Nineteen drug-naive, first-episode patients with a DSM IV diagnosis of paranoid schizophrenia were compared with matched healthy controls. Flow cytometry was used to assess platelet surface expression levels of GPIb, alpha(IIb)beta(IIIa), CD62, and CD63. Adenosine diphosphate-induced platelet aggregation was assayed. Results: The schizophrenic patients had a significantly (p < .0001) increased number of 68145 +/- 8260.1 alpha(IIb)beta(IIIa) receptors, platelet compared with 56235 +/- 8079.4 receptors, platelet in healthy controls. Conclusions: Patients with schizophrenia have increased platelet expression of alpha(IIb)beta(IIIa), which may contribute to their increased risk of cardiovascular illness compared with the general population. (C) 2002 Society of Biological Psychiatry.